Measuring the relative potencies of bupivacaine and ropivacaine in spinal anesthesia

Regional Anesthesia and Pain Medicine

Volumn 34, Issue 1, 2009, Pages 73-74

  Wildsmith, J A W ^a   Selander, Dag E ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Selmedic AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

CONTINUOUS INFUSION; DRUG POTENCY; HUMAN; LETTER; MINIMUM LUNG ALVEOLUS CONCENTRATION; NERVE CONDUCTION; PRIORITY JOURNAL; QUALITY CONTROL; SPINAL ANESTHESIA;

EID: 60749101319     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181933f63     Document Type: Letter

References (5)

1. Butterworth J. Potency ratios for local anesthetics in regional blocks: how long must we wait? Reg Anesth Pain Med. 2008;33:1-3.
2. Michalek-Sauberer A, Kozek-Langenecker SA, Heinzl H, et al. Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen. Reg Anesth Pain Med. 2008;33:4-9.
3. Hocking G, Wildsmith JAW. Intrathecal drug spread. Br J Anaesth. 2004;93:568-578.
4. Stienstra R, Veering BT. Intrathecal drug spread: is it controllable? Reg Anesth Pain Med. 1998;23:347-351.
5. Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg. 1985;64:715-730.